Atlas Trials

Joshua M Hare

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Joshua M Hare

RecordFirmDate
The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. (NCT02503280)Joshua M Hare2025-03-01
Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 (NCT04490486)Joshua M Hare2022-10-01
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) (NCT04776239)Joshua M Hare2021-08-16
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy (NCT04476901)Joshua M Hare2021-05-07
Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis (NCT03058068)Joshua M Hare2020-12-01
Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain (NCT03487731)Joshua M Hare2020-12-01
AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) (NCT02677350)Joshua M Hare2019-12-01
The CHILD Trial: Hypoplastic Left Heart Syndrome Study. (NCT03406884)Joshua M Hare2019-10-16
Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. (NCT03059355)Joshua M Hare2018-04-12
Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression (NCT02675556)Joshua M Hare2017-10-31
Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects (NCT02886884)Joshua M Hare2017-10-20

Track Joshua M Hare automatically

Every clearance here is in the API, with alerts when new ones post.